These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25757680)

  • 1. Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.
    Berstein LM; Vasilyev DA; Iyevleva AG; Boyarkina MP; Poroshina TE; Khadzhimba AS; Imyanitov EN
    Future Oncol; 2015; 11(5):759-70. PubMed ID: 25757680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes].
    Bershteĭn LM; Vasil'ev DA; Ievleva AG; Imianitov EN
    Vopr Onkol; 2013; 59(6):714-20. PubMed ID: 24624779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin, an old drug, brings a new era to cancer therapy.
    He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
    Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
    Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
    Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential sensitivity to metformin of the diabetics suffering and not suffering with cancer: a pharmacogenetic study].
    Bershteĭn LM; Ievleva AG; Vasil'ev DA; Kovalenko IM; Imianitov EN
    Vestn Ross Akad Med Nauk; 2013; (12):58-63. PubMed ID: 24741944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].
    Bershteĭn LM; Turkevich EA; Boiarkina MP
    Vopr Onkol; 2012; 58(2):194-8. PubMed ID: 22774523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes.
    Arshad OA; Venkatasubramani PS; Datta A; Venkatraj J
    IEEE J Biomed Health Inform; 2016 Jan; 20(1):399-407. PubMed ID: 25389247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: fifty-two not out.
    Campbell IW
    J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
    Henderson D; Frieson D; Zuber J; Solomon SS
    Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].
    Winkler G
    Orv Hetil; 2016 Jun; 157(23):882-91. PubMed ID: 27233831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metformin: the overlap of diabetology and oncology].
    Anděl M; Skrha P; Trnka J
    Vnitr Lek; 2013 Aug; 59(8):738-42. PubMed ID: 24007233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: an old drug with new potential.
    Hajjar J; Habra MA; Naing A
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1511-7. PubMed ID: 23978196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women].
    Bershteĭn LM; Vasil'ev DA; Kovalenko IG; Poroshina TE; Kisel'nikov KS; Boiarkina MP; Zaĭtsev AN
    Vopr Onkol; 2012; 58(1):45-9. PubMed ID: 22629827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes.
    Adamia N; Virsaladze D; Charkviani N; Skhirtladze M; Khutsishvili M
    Georgian Med News; 2007 Apr; (145):52-5. PubMed ID: 17525501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.